IME
vs
S
S&P/ASX 300
IME
Over the past 12 months, IME has significantly outperformed S&P/ASX 300, delivering a return of +38% compared to S&P/ASX 300's +2% growth.
Stocks Performance
IME vs S&P/ASX 300
Performance Gap
IME vs S&P/ASX 300
Performance By Year
IME vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
ImExHS Ltd
Glance View
ImExHS Ltd is a health technology company that builds software for medical imaging. Its products help hospitals, imaging clinics, and radiologists store, view, move, and report on scans such as X-rays, CTs, and MRIs. In plain terms, it sells the digital tools that let imaging teams handle pictures and reports more smoothly than older film-based or disconnected systems. The company makes money by licensing and subscribing customers to its software and related services. Its main customers are healthcare providers and radiology groups that need a secure way to manage large image files, connect different sites, and let doctors access studies from anywhere. ImExHS sits in the middle of the imaging workflow, linking the equipment that creates scans with the clinicians who need to read them. What makes its business model different is that it is focused on the infrastructure behind medical imaging, not on making scanners or running hospitals. That gives it a role as a specialist software layer in a highly regulated workflow where speed, reliability, and secure data sharing matter. Once installed, this kind of software can become deeply tied to a customer’s daily operations, which makes it an important part of the imaging business rather than a one-time product sale.
